Univercells announces the acquisition of RLM Consulting, a company highly specialized in providing regulatory guidance at all stages of the medicinal product development.
Jumet, Belgium, April 27, 2022
Univercells S.A., a Belgian biotech company dedicated to ensuring that everyone has access to biologics everywhere in the world, announced today that RLM Consulting SRL joined the Group as a new affiliate. RLM Consulting is a Belgian-based company that was created in 2006 and that provides regulatory affairs support at all stages of the medicinal product development, from discovery research through preclinical and clinical testing, up to and beyond submission of the dossier required for marketing authorization.
Like the other affiliates of Univercells Group, RLM Consulting will continue to conduct its activities on an autonomous basis. Mr. René Mignolet, RLM Consulting’s founder will thus stay onboard to run the company’s day-to-day business activities as Head of Operations. RLM Consulting’s mission also remains unchanged, but thanks to the association between the companies, RLM Consulting will be able to offer its customers access to new services including Univercells’ expertise in manufacturing process design and testing of investigational medicinal products. As an international reference in regulatory affairs, RLM Consulting's unique know-how will accelerate the development of Univercells’ projects, including those of its affiliates.
René Mignolet, Founder of RLM Consulting stated: “We are excited to join Univercells Group, a fast-growing company with a noble mission: developing new ways to expand access to life-changing medicines. By joining the Group, our clients will gain access to Univercells’ know-how for the design of the biomanufacturing process and the testing of experimental drugs, as well as, access to GMP manufacturing services for gene therapy and viral vector-based vaccines”.
David Louvet, Chief Operating Officer of Univercells Group added: “We are honored to welcome RLM Consulting into the Group. Their professionalism and worldwide expertise in regulatory affairs will be a great asset for us. RLM Consulting’s goals and ambitions are also close to ours. We are therefore convinced that bringing RLM Consulting into the group will facilitate the access to safe and affordable healthcare and biological products, and thereby our growth”.
Read the press release in French here.
Read the press release in Dutch here.